Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Pfizer boss refuses to testify to EU Parliament COVID panel — again

Pfizer boss refuses to testify to EU Parliament COVID panel — again

‘We have no further information to share,’ says Albert Bourla, who bailed out of an earlier appointment in October.
Pfizer Chief Executive Officer Albert Bourla has once again declined to testify before the European Parliament’s special COVID committee.

That’s strike two. 

"Since the October COVID hearing, we have no further information to share with the Committee, so respectfully decline the invitation to again revisit these issues," states the letter from Bourla dated December 2 and seen by POLITICO.

Bourla previously pulled out of an appointment to testify before the committee in October, at which he was expected to face tough questions on how secretive vaccine deals were struck. That decision followed an audit report into the EU's vaccine procurement strategy that raised new questions about contact between the pharma CEO and European Commission President Ursula von der Leyen that preceded a multibillion-euro vaccine contract.

On October 14, the European Public Prosecutor's Office confirmed it had an ongoing investigation into the EU's COVID vaccine purchases, but has not yet specified who is being investigated or which of the EU's vaccine contracts are under scrutiny.

At the October 10 COVI hearing, the company’s president of international developed markets, Janine Small, faced repeated questions from the committee on Bourla's absence, one of which was even taped to some MEPs' laptops. She also took questions on vaccine contract negotiations and the jabs themselves, including one from Dutch MEP Robert Roos (ECR group) about whether the vaccine was tested for its ability to prevent transmission before entering the market. That question — and Small's answer — landed Roos an appearance on Tucker Carlson's Fox News talk show.

But, in the end, it seems Small was just no substitute for Bourla.

So, on October 28, the COVID committee extended a second invitation to the CEO.

“Our committee felt that during the previous hearing with representatives of the pharmaceutical industry, where Pfizer was represented by Mrs. Janine Small, important questions regarding the advanced purchase agreements between the European Union and Pfizer, which fall under the responsibility of the CEO and of which only he has the authority to respond to them, remained unanswered,” COVID committee chair Kathleen Van Brempt (S&D group) said in a statement today. 

“As chair of the COVI committee, I deeply regret Dr. Bourla’s refusal to discuss this matter with the Members of the European Parliament,” she said. "As a co-legislator of the European budget, the Parliament has the right to obtain full transparency on the modalities of these expenditures and the preliminary negotiations leading up to them."

But for Pfizer, it seems there’s just nothing new to say. 

Pfizer has provided input to the Special Committee on the COVID-19 Pandemic, and the wider European Parliament, as it seeks to understand and learn from the pandemic response,” a company spokesperson told POLITICO.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
Hungary Ranked Among the World’s Safest Travel Destinations for 2025
G7 Leaders Fail to Reach Consensus on Key Global Issues
FBI and Senate Investigate Allegations of Chinese Plot to Influence the 2020 Election in Biden’s Favor Using Fake U.S. Driver’s Licenses
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Shock Within Iran’s Leadership: Khamenei’s Failed Plan to Launch 1,000 Missiles Against Israel
Wreck of $17 Billion San José Galleon Identified Off Colombia After 300 Years
Man Convicted of Fraud After Booking Over 120 Free Flights Posing as Flight Attendant
Iran Launches Extensive Missile Attack on Israel Following Israeli Strikes on Nuclear Sites
Beata Thunberg Rebrands as Beata Ernman Amidst Sister's Activism Controversy
Hungarian Parliament Approves Citizenship Suspension Law
Prime Minister Orbán Criticizes EU's Ukraine Accession Plans
Hungarian Delicacies Introduced to Japanese Market
Hungary's Industrial Output Rises Amid Battery Sector Slump
President Sulyok Celebrates 15 Years of Hungarian Unity Efforts
Hungary's Szeleczki Shines at World Judo Championships
Visegrád Construction Trends Diverge as Hungary Lags
Hungary Hosts National Quantum Technology Workshop
Hungarian Animation Featured at Annecy Festival
Israel Issues Ultimatum to Iran Over Potential Retaliation and Nuclear Facilities
UK and EU Reach New Economic Agreement
Coinbase CEO Warns Bitcoin Could Supplant US Dollar Amid Mounting National Debt
Trump to Iran: Make a Deal — Sign or Die
Operation "Like a Lion": Israel Strikes Iran in Unprecedented Offensive
Israel Launches 'Operation Rising Lion' Targeting Iranian Nuclear and Military Sites
UK and EU Reach Agreement on Gibraltar's Schengen Integration
Israeli Finance Minister Imposes Banking Penalties on Palestinians
U.S. Inflation Rises to 2.4% in May Amid Trade Tensions
Trump's Policies Prompt Decline in Chinese Student Enrollment in U.S.
Global Oceans Near Record Temperatures as CO₂ Levels Climb
Trump Announces U.S.-China Trade Deal Covering Rare Earths
Smuggled U.S. Fuel Funds Mexican Cartels Amid Crackdown
Austrian School Shooting Leaves Nine Dead in Graz
Bezos's Lavish Venice Wedding Sparks Local Protests
Europe Prepares for Historic Lunar Rover Landing
Italian Parents Seek Therapy Amid Lengthy School Holidays
British Fishing Vessel Seized by France Fined €30,000
Dutch Government Collapses Amid Migration Policy Dispute
UK Commits to 3.5% GDP Defence Spending Under NATO Pressure
Germany Moves to Expedite Migrant Deportations
US Urges UK to Raise Defence Spending to 5% of GDP
Israeli Forces Intercept Gaza-Bound Aid Vessel Carrying Greta Thunberg
IMF Warns of Severe Global Trade War Impacts on Emerging Markets
Low Turnout Jeopardizes Italy's Citizenship Reform Referendum
Transatlantic Interest Rate Divergence Widens as Trump Pressures Powell
EU Lawmaker Calls for Broader Exemptions in Supply Chain Legislation
France's Defense Spending Plans Threatened by High National Debt
European Small-Cap Stocks Outperform U.S. Rivals Amid Growth Revival
Switzerland Proposes $26 Billion Capital Increase for UBS
×